Gattei V - Search Results

1

CDKN1B mutation and copy number variation are associated with tumor aggressiveness in luminal breast cancer.

Viotto D, Russo F, Anania I, Segatto I, Rampioni Vinciguerra GL, Dall'Acqua A, Bomben R, Perin T, Cusan M, Schiappacassi M, Gerratana L, D'Andrea S, Citron F, Vit F, Musco L, Mattevi MC, Mungo G, Nicoloso MS, Sonego M, Massarut S, Sorio R, Barzan L, Franchin G, Giorda G, Lucia E, Sulfaro S, Giacomarra V, Polesel J, Toffolutti F, Canzonieri V, Puglisi F, Gattei V, Vecchione A, Belletti B, Baldassarre G. Viotto D, et al. Among authors: gattei v. J Pathol. 2021 Feb;253(2):234-245. doi: 10.1002/path.5584. Epub 2020 Dec 4. J Pathol. 2021. PMID: 33140857 Free PMC article.

2

Reed-Sternberg cells of classical Hodgkin's disease react with the plasma cell-specific monoclonal antibody B-B4 and express human syndecan-1.

Carbone A, Gloghini A, Gattei V, Degan M, Improta S, Aldinucci D, Canzonieri V, Perin T, Volpe R, Gaidano G, Zagonel V, Pinto A. Carbone A, et al. Among authors: gattei v. Blood. 1997 May 15;89(10):3787-94. Blood. 1997. PMID: 9160685 Free article.

3

Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells.

Aldinucci D, Poletto D, Gloghini A, Nanni P, Degan M, Perin T, Ceolin P, Rossi FM, Gattei V, Carbone A, Pinto A. Aldinucci D, et al. Among authors: gattei v. Am J Pathol. 2002 Feb;160(2):585-96. doi: 10.1016/S0002-9440(10)64878-X. Am J Pathol. 2002. PMID: 11839579 Free PMC article.

4

ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations.

Zucchetto A, Bomben R, Bo MD, Nanni P, Bulian P, Rossi FM, Del Principe MI, Santini S, Del Poeta G, Degan M, Gattei V. Zucchetto A, et al. Among authors: gattei v. Cytometry B Clin Cytom. 2006 Jul 15;70(4):284-92. doi: 10.1002/cyto.b.20127. Cytometry B Clin Cytom. 2006. PMID: 16906587 Free article.

5

Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia.

Spessotto P, Zucchetto A, Degan M, Wasserman B, Danussi C, Bomben R, Perris R, Canzonieri V, Radillo O, Colombatti A, Gattei V. Spessotto P, et al. Among authors: gattei v. Matrix Biol. 2007 Jul;26(6):473-84. doi: 10.1016/j.matbio.2007.04.003. Epub 2007 Apr 11. Matrix Biol. 2007. PMID: 17482449

6

Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia.

Gattei V, Bulian P, Del Principe MI, Zucchetto A, Maurillo L, Buccisano F, Bomben R, Dal-Bo M, Luciano F, Rossi FM, Degan M, Amadori S, Del Poeta G. Gattei V, et al. Blood. 2008 Jan 15;111(2):865-73. doi: 10.1182/blood-2007-05-092486. Epub 2007 Oct 24. Blood. 2008. PMID: 17959854 Free article.

7

Human immunodeficiency virus-associated precursor T-lymphoblastic leukemia/lymphoblastic lymphoma: report of a case and review of the literature.

Lorenzon D, Perin T, Bulian P, De Re V, Caggiari L, Michieli M, Manuele R, Spina M, Gattei V, Fasan M, Tirelli U, Canzonieri V. Lorenzon D, et al. Among authors: gattei v. Hum Pathol. 2009 Jul;40(7):1045-9. doi: 10.1016/j.humpath.2008.12.021. Epub 2009 May 7. Hum Pathol. 2009. PMID: 19427018 Review.

8

Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.

Bomben R, Dal-Bo M, Benedetti D, Capello D, Forconi F, Marconi D, Bertoni F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Luciano F, Sozzi E, Cattarossi I, Zucchetto A, Rossi FM, Bulian P, Zucca E, Nicoloso MS, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano G, Gattei V. Bomben R, et al. Among authors: gattei v. Clin Cancer Res. 2010 Jan 15;16(2):620-8. doi: 10.1158/1078-0432.CCR-09-1638. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068100

9

Microenvironmental interactions in chronic lymphocytic leukemia: hints for pathogenesis and identification of targets for rational therapy.

Dal Bo M, Bomben R, Zucchetto A, Del Poeta G, Gaidano G, Deaglio S, Efremov DG, Gattei V. Dal Bo M, et al. Among authors: gattei v. Curr Pharm Des. 2012;18(23):3323-34. doi: 10.2174/138161212801227078. Curr Pharm Des. 2012. PMID: 22591383 Review.

10

TLR9 signaling defines distinct prognostic subsets in CLL.

Efremov DG, Bomben R, Gobessi S, Gattei V. Efremov DG, et al. Among authors: gattei v. Front Biosci (Landmark Ed). 2013 Jan 1;18(1):371-86. doi: 10.2741/4108. Front Biosci (Landmark Ed). 2013. PMID: 23276930 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

288 results

Search Page